Inhibition of METTL3 Attenuates Renal Fibrosis by Upregulating ABCG2 m6A Modifications via IGF2BP2‐Dependent Mechanisms in Hyperuricemic Nephropathy. This evidence concerns the gene ABCG2 and renal fibrosis.